Literature DB >> 377118

What if multiple sclerosis isn't an immunological or a viral disease? The case for a circulating toxin.

F Wolfgram.   

Abstract

The literature contains studies on many causes of demyelination: Vascular occlusion--exogenous toxins--allergic reactions--and virus diseases. There remains, however, a small group of conditions which seems to have been ignored almost completely in discussions of cerebral demyelination. These consist of brain damage apparently resulting from some toxin liberated within the human body and not obtained from the outside.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377118     DOI: 10.1007/bf00963827

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  51 in total

1.  CENTRAL PONTINE MYELINOLYSIS.

Authors:  J L CHASON; J W LANDERS; J E GONZALEZ
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-08       Impact factor: 10.154

2.  CENTRAL PONTINE MYELINOLYSIS. A REPORT OF TWO CASES.

Authors:  F P ALEU; R D TERRY
Journal:  Arch Pathol       Date:  1963-08

3.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

4.  Central demyelination of the corpus callosum (Marchiafava-Bignami disease) with report of a second case in Great Britain.

Authors:  R IRONSIDE; F D BOSANQUET; W H McMENEMEY
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

5.  Peripheral neuropathy in multiple sclerosis.

Authors:  J HASSON; R D TERRY; H M ZIMMERMAN
Journal:  Neurology       Date:  1958-07       Impact factor: 9.910

6.  Neurologic sequelae of spinal anesthesia.

Authors:  E D FRIEDMAN
Journal:  N Y State J Med       Date:  1953-08-15

7.  The etiology of meat intoxication in the Eck fistula dog.

Authors:  A G RIDDELL; P N KOPPLE; W V McDERMOTT
Journal:  Surgery       Date:  1954-09       Impact factor: 3.982

8.  Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands.

Authors:  D C Poskanzer; A M Walker; J Yonkondy; J L Sheridan
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

Review 9.  Uremia (first of two parts). Uremia. I.

Authors:  J P Merrill; C L Hampers
Journal:  N Engl J Med       Date:  1970-04-23       Impact factor: 91.245

10.  [Permeability of the cerebral vessels. VI. Experimental demyelination produced by substances acting on the hemato-encephalic barrier].

Authors:  R Gonsette; G Andre-Balisaux; P Delmotte
Journal:  Acta Neurol Psychiatr Belg       Date:  1966-04
View more
  3 in total

Review 1.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

Review 2.  Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.

Authors:  Véronique Ferret-Sena; Carlos Capela; Armando Sena
Journal:  Int J Mol Sci       Date:  2018-06-01       Impact factor: 5.923

Review 3.  The pathogenesis of multiple sclerosis. Additional considerations.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1993-04       Impact factor: 3.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.